Showing results (1881-1890 of 2,171) with videos related to
Sort By:
Pageof 218
European Journal of Heart Failure|March 7, 2024
Diuretic use and outcomes in patients with heart failure with reduced ejection fraction: Insights from the VICTORIA trialJustin Ezekowitz, Wendimagegn Alemayehu, Frank Edelmann, et al.AIDS (London, England)|July 19, 2006
Effectiveness of highly-active antiretroviral therapy by race/ethnicityMichael J Silverberg, Scott A Wegner, Mark J Milazzo, et al.The American Journal of Cardiology|February 22, 2005
Prognostic usefulness of white blood cell count and temperature in acute myocardial infarction (from the CARDINAL Trial)Manesh R Patel, Kenneth W Mahaffey, Paul W Armstrong, et al.Circulation|June 20, 2001
Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin t-positive status: the paragon-B troponin T substudyL K Newby, E M Ohman, R H Christenson, et al.Journal of the American Heart Association|November 8, 2021
Blood Pressure and Safety Events With Vericiguat in the VICTORIA TrialCarolyn S P Lam, Hillary Mulder, Yuri Lopatin, et al.Circulation. Cardiovascular Quality and Outcomes|August 1, 2013
Global variation in quality of care among patients hospitalized with acute heart failure in an international trial: findings from the acute study clinical effectiveness of nesiritide in decompensated heart failure trial (ASCEND-HF)Jonathan G Howlett, Justin A Ezekowitz, Mohua Podder, et al.Atherosclerosis|April 25, 2017
Whole blood sequencing reveals circulating microRNA associations with high-risk traits in non-ST-segment elevation acute coronary syndromeAlice Wang, Lydia Coulter Kwee, Elizabeth Grass, et al.Circulation|August 16, 2000
Dose-finding, safety, and tolerability study of an oral platelet glycoprotein IIb/IIIa inhibitor, lotrafiban, in patients with coronary or cerebral atherosclerotic diseaseR A Harrington, P W Armstrong, C Graffagnino, et al.Diabetes Care|January 10, 2018
Increased Risk of Severe Hypoglycemic Events Before and After Cardiovascular Outcomes in TECOS Suggests an At-Risk Type 2 Diabetes Frail Patient PhenotypeEberhard Standl, Susanna R Stevens, Paul W Armstrong, et al.The Canadian Journal of Cardiology|August 18, 2014
Providing Rapid Out of Hospital Acute Cardiovascular Treatment 3 (PROACT-3)Justin A Ezekowitz, Robert C Welsh, Courtney Gubbels, et al.Pageof 218